Biotin functions as a coenzyme for four carboxylases involved in energy metabolism in mammals. Besides these classical functions, biotin has novel functions in the cellular processes via the modulation of gene expression. In this study, we examined the alteration of gene expression by biotin administration in the liver of streptozotocin (STZ)-induced diabetic rats. In comparison with the control, the mRNA levels of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase were significantly reduced and glucokinase mRNA was increased 3 h after the administration of biotin or insulin. The expression of hepatocyte nuclear factor 4, one of the transcription factors responsible for gluconeogenic gene expression, was decreased by biotin at both mRNA and protein levels. In addition, forkhead box O1 and sterol regulatory element-binding protein 1c mRNA expression that was enhanced by the insulin treatment was inversely decreased by biotin. These results indicate that biotin repressed the gluconeogenic genes and their transcription factors via a pathway independent of insulin-signaling and could improve the diabetic condition.
Biotin functions as a coenzyme for four carboxylases involved in energy metabolism in mammals. Besides these classical functions, biotin has novel functions in the cellular processes via the modulation of gene expression. In this study, we examined the alteration of gene expression by biotin administration in the liver of streptozotocin (STZ)-induced diabetic rats. In comparison with the control, the mRNA levels of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase were significantly reduced and glucokinase mRNA was increased 3 h after the administration of biotin or insulin. The expression of hepatocyte nuclear factor 4, one of the transcription factors responsible for gluconeogenic gene expression, was decreased by biotin at both mRNA and protein levels. In addition, forkhead box O1 and sterol regulatory element-binding protein 1c mRNA expression that was enhanced by the insulin treatment was inversely decreased by biotin. These results indicate that biotin repressed the gluconeogenic genes and their transcription factors via a pathway independent of insulin-signaling and could improve the diabetic condition.
Key words: biotin; gene expression; gluconeogenesis; streptozotocin (STZ) diabetic rat Biotin, a water-soluble vitamin, serves as a coenzyme for carboxylases of pyruvate, propionyl-CoA, 3-methylcrotonyl-CoA and acetyl-CoA, and plays important roles in the metabolism of carbohydrates, lipids, and amino acids in mammals. 1, 2) These biotin-dependent carboxylases transform into holocarboxylases as a result of covalent binding between a specific lysine residue of apocarboxylases and biotin in the presence of holocarboxylase synthetase (HCS). 3) In addition to these well-known roles, novel functions of biotin have been reported. Supplementation of biotin in cultured human cells modulates the expression of genes related to cell growth and immune response. [4] [5] [6] [7] Furthermore, mRNA of hepatic glucokinase (GCK), an initial glycolytic enzyme, is increased by biotin administration in fasting or streptozotocin (STZ)-induced diabetic rats; [8] [9] [10] [11] in contrast, the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase (PCK1), mRNA inversely decreases. 12) Recently, biotinyl histones have been discovered in biotin-supplemented cultured human cells, and this novel histone modification is thought to repress or enhance classical histone modifications, such as phosphorylation, acetylation and methylation, and to bring about epigenetic alterations in chromatin. 13, 14) We have previously observed that an intraperitoneal administration of biotin for 15 d partially improved impaired glucose tolerance in response to oral glucose load in STZ-induced diabetic rats and enhanced the enzymatic activities of hepatic and pancreatic GCK without increasing the plasma insulin level. 15) These phenomena might be caused by the modulation of gene expression due to the biotin administration.
In this study, we demonstrate the effect of a single biotin administration on hepatic gene expression in STZ diabetic rats. Biotin modulated gene expression of not only gluconeogenic and glycolytic enzymes but also the transcription factors involved in carbohydrate and lipid metabolism. This is the first observation that biotin decreases the expression of certain transcription factors causing the repression of gluconeogenic gene expression. However, these effects were distinguished from the action of insulin. These results indicate that biotin modulates gene expression in an insulin-independent manner and may have the ability to improve the diabetic condition.
Materials and Methods
Animal experiments. We obtained 6-week-old male Sprague-Dawley rats from Japan SLC (Hamamatsu, Japan) and injected them intraperitoneally with 80 mg/ kg body weight of STZ (Wako Pure Chemical Industries, Osaka, Japan). The blood glucose level of the treated rats measured 2 d later was >350 mg/dl. For 2 d, these diabetic rats were fed on a high-carbohydrate diet containing 65% glucose 12) and distilled water with free access, and they were then sacrificed 3 h after an intraperitoneal administration of 1.0 mg/kg body weight of biotin (Wako Pure Chemical Industries), 20 U/kg body weight of insulin (Wako Pure Chemical Industries), or saline as the control. The administration level of biotin in this study was approximately 500 times of daily intake level of biotin from the AIN-93G standard diet. The rats were kept under the fasting condition after the administration.
The experimental plan for the present study was approved by the Animal Research-Animal Care Committee of the Graduate School of Agricultural Science, Tohoku University. The entire experiment was performed by following the guidelines framed by this committee in accordance with the Japanese governmental legislation (1980) . The same committee supervised the care and use of the rats in this study.
Northern blot analysis. Total RNA was extracted from the liver by using the phenol/guanidine isothiocyanate based reagent, ISOGEN (Nippon Gene, Toyama, Japan), as detailed in the instruction manual. The RNA samples were then denatured and loaded on to 1.2% agarose gel containing formaldehyde. After electrophoresis, the RNAs were transferred to a Hybond N+ nylon membrane (Amersham Biosciences, Piscataway, NJ, USA) by the capillary method. The RNA blotted filters and [
32 P]dCTP (MP Biomedicals, Morgan Irvine, CA, USA) labeled cDNA were incubated in an ExpressHyb hybridization solution (Clontech Laboratories, Palo Alto, CA, USA) for 1.5 h at 68 C. After hybridization, the filters were washed twice each with 2Â SSC (150 mM sodium chloride and 150 mM sodium citrate) for 30 min and with 0:1Â SSC for 40 min; they were then exposed on a Fuji imaging plate (Fuji Photo Film, Tokyo, Japan) for an adequate period of time and analyzed using the BioImage analyzer FLA-2000 (Fuji Photo Film). The relative expression levels of mRNA were normalized by the amount of -tubulin mRNA.
Quantitative reverse transcriptase-mediated PCR (RT-PCR). Four micrograms of total RNA from the liver was used as the template for cDNA synthesis, as described previously. 16) An aliquot of synthesized cDNA was used as the template for quantitative PCR that was carried out using an Applied Biosystems 7300 sequence detection system (Foster City, CA, USA). The cDNAs of glucose-6-phosphatase (G6PC) and other genes were amplified by using cDNA-specific primers (shown in Table 1 ) in SYBR Premix Ex Taq (Takara Bio, Shiga, Japan). The relative expression level of each mRNA was normalized by the amount of eukaryotic translation elongation factor 11 (EEF1A1) mRNA.
Western blot analysis. Rat liver was homogenized in a PBS buffer containing 1 mM phenylmethylsulfonyl fluoride. The protein concentration in the lysate was measured with a protein assay reagent (Bio-Rad, Hercules, CA, USA). Fifteen micrograms of protein was denatured in an SDS gel-loading buffer, resolved by 10% SDS-PAGE, and transferred on to a PVDF membrane. After blocking for 1 h with TBS-T (10 mM Tris-HCl at pH 7.4, 150 mM NaCl and 0.1% Tween 20) containing 5% fat-free milk, the membrane was incubated with hepatocyte nuclear factor 4 (HNF4) or peroxisome proliferator-activated receptor coactivator (PGC-1) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and detected with the ECL plus reagent (Amersham Biosciences). The relative expression level of each protein was normalized by the amount of total proteins stained by Coomassie Brilliant Blue R-250 in the gel and quantified by a densitometric scan.
Chromatin immunoprecipitation assay. The chromatin immunoprecipitation (ChIP) assay based on the methods of Farnham and colleagues (http://www. genomecenter.ucdavis.edu/farnham/protocols/tissues. html) was conducted by using a kit from Upstate Biotechnology (Lake Placid, NY, USA). The immunoprecipitated DNAs were used as the template for PCR that was performed by using specific primers for the promoter region of the PCK1 17) or G6PC genes (Table 1) with an Applied Biosystems 7300 sequence detection system. The relative amounts of DNA of the PCK1 or G6PC genes were normalized by the amount of EEF1A1 gene DNA.
Measurement of the plasma metabolic parameters.
The concentrations of blood glucose, total cholesterol, and triglycerides were determined by using kits purchased from Wako Pure Chemical Industries. The plasma insulin concentration was measured by a radioimmunoassay, using a kit purchased from Shionogi & Co. (Osaka, Japan).
Statistical analysis. Each result is expressed as the mean AE standard error (S.E). Differences in the data among the STZ groups were analyzed by a one-way analysis of variance, and multiple comparisons were then performed by using Scheffé's test.
Results
Effects of biotin on the blood glucose, insulin, and lipid levels in STZ rats STZ-induced diabetic rats were divided into three groups, i.e., biotin-, insulin-, and saline (control)-treated groups. After administration, blood samples were obtained from the caudal vein, and the blood glucose level was determined. In the insulin-treated group, the blood glucose level significantly decreased 3 h after administration, as compared to the STZ control group, while that in the biotin-treated group remained unchanged ( Table 2) . The plasma insulin level in the biotin-treated and STZ control groups 3 h after administration also remained unchanged. We have previously reported that biotin administration for 15 d improved the glucose tolerance in STZ rats without enhancing the plasma insulin level. 15) The present result partially corresponds with our earlier observation; however, a single administration of biotin did not affect the plasma glucose level. Both the plasma total cholesterol and triglyceride levels decreased in the biotin-treated group, as compared with the STZ control group, although the differences were not significant ( Table 2) . Biotin might improve hyperlipidemia associated with type I diabetes.
Effects of the biotin administration on the hepatic gene expression of gluconeogenic enzymes in STZ rats
To elucidate the effect of biotin on hepatic gene expression, the rats were sacrificed 3 h after administration, and total RNA was isolated from the liver and subjected to Northern blot or quantitative RT-PCR analyses. The PCK1 mRNA level was increased in the STZ control rats, as compared to the normal nondiabetic rats, and it was decreased by insulin administration (Fig. 1A and B) . The abundance of PCK1 mRNA was significantly reduced in the biotin-treated group, as compared to the STZ control group. The mRNA of G6PC, the enzyme catalyzing the final step of gluconeogenesis, was also significantly decreased by up to 50% in the biotin-treated group (Fig. 1C) . On the other hand, the mRNA of GCK, an initial enzyme of glycolysis, in the liver was significantly increased in the biotin-treated group. These results indicate that the administration of biotin, like the action of insulin, stimulated glycolysis and inhibited gluconeogenesis in the liver of STZ diabetic rats. We have previously observed that the administration of biotin enhanced hepatic GCK activity by up to 3.4 times in STZ rats. 15) This increase in GCK enzymatic activity could have been due to the enhancement of GCK mRNA expression by the biotin administration. Insulin stimulates lipogenesis by both activating lipogenic enzymes and enhancing their mRNAs. Fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACACA) mRNAs were upregulated by the insulin administration in STZ rats (Fig. 2) . In addition to this result, the mRNA levels of the transcription factors, namely, sterol regulatory element-binding protein 1c (SREBP1c) and forkhead box O1 (FoxO1), also increased after the insulin treatment (Fig. 2) . However, the mRNA levels of these genes were inversely decreased in the biotin-treated group. These results indicate that the effect of biotin on gene expression was clearly distinguished from the insulin action.
Effects of biotin on the expression of transcription factors involved in the regulation of the PCK1 gene
Transcriptional regulation of the PCK1 gene in the liver, kidney and, adipose tissue has been well characterized. [18] [19] [20] [21] [22] [23] [24] Several transcription factors, including cAMP responsive element-binding protein (CREB), CAAT enhancer-binding protein (C/EBP), glucocorticoid receptor (GR), FoxO1, and HNF4, bind on their cognate sequences in the 5 0 -upstream region of the PCK1 gene and are responsible for regulating its transcriptional level. In the Western blot analysis using the whole liver lysate, HNF4 expression was significantly reduced in the biotin-treated group, as compared to the STZ control group, while the expression of the other transcription factors and of coactivator PGC-1 remained unchanged (Fig. 3A) . None of the transcription factors and coactivator analyzed here could be detected in the insulin-treated group, although the reason for this was not clear. The mRNA level of HNF4 was also significantly decreased in the biotin-treated group (60% of the control, Fig. 3B ). The PGC-1 mRNA level was also significantly reduced in the biotin-treated group in comparison with the STZ control group. To determine the amount of HNF4 recruited on the PCK1 promoter region in the nucleus, we performed a ChIP assay. The result (Fig. 4 ) obtained suggests that, as compared to the STZ control group, the amount of HNF4 on the PCK1 promoter was slightly decreased in the biotintreated group. These results suggest that the repression of PCK1 gene expression by the biotin treatment was caused by a decrease in the HNF4 level in the liver of the STZ rats.
Effect of biotin on the mRNA levels of biotin-related genes Soloezano-Vargas et al. have reported that the mRNA levels of the biotin-related proteins, namely, HCS, ACACA, and propionyl-CoA carboxylase subunit (PCCA), were decreased by the depletion of biotin from the culture medium and were restored by biotin supplementation in HepG2 cells. 25) Furthermore, the mRNA expression of the biotin transporter sodiumdependent multivitamin transporter (SMVT) and pyruvate carboxylase was also decreased in biotin-deficient rat liver and human leukocytes. [26] [27] [28] [29] [30] In addition to these genes, the mRNA level of biotinidase was analyzed by quantitative RT-PCR. The abundance of mRNAs of HCS and SMVT remained unchanged by the biotin treatment in STZ rats (Fig. 5) . However, the mRNA levels of biotinidase and PCCA were significantly reduced in the biotin-treated group, as compared to the STZ control group. These results suggest that the effect of biotin on gene expression could occur in a cell-or organ-specific manner, depending on the biotin status.
Discussion
In this study, we found that the mRNA levels of several genes and transcription factors related to gluconeogenesis, glycolysis, and fatty acid synthesis in the liver of STZ-induced diabetic rats were modulated by a single intraperitoneal administration of biotin. The effects of biotin on the gene expression of the enzymes involved in gluconeogenesis and glycolysis (PCK1, G6PC, and GCK) were similar to those of insulin; however, its effects on the expression of FAS and its regulator SREBP1c were different from those of insulin. The plasma insulin level was not altered by the biotin administration. Therefore, the effect of biotin was not a consequence of either the stimulation of insulin secretion from pancreatic -cells or the enhancement of insulin sensitivity in the liver. We demonstrated clearly that biotin has a unique function for the modulation of gene expression in a manner different from that of insulin.
Our results correspond with the earlier observations that biotin decreased the abundance of mRNA of the PCK1 genes in the liver of STZ rats. 12) Although blood glucose level did not change within 3 h after the administration of biotin, the mRNA levels of the hepatic gluconeogenic genes, PCK1 and G6PC, were significantly downregulated (by up to 70% and 50% of the control levels, respectively) in STZ-induced diabetic rats. This is the first observation that the abundance of G6PC mRNA was reduced by biotin. These results indicate that biotin inhibits the gluconeogenic pathway at the mRNA level. Insulin is well known as the only endocrine substance to repress gluconeogenesis, apart from the thiazolidinedione group of antidiabetic therapeutic agents which are ligands of peroxisome proliferator-activated receptor . Our observation suggests that biotin, an essential nutrient, administered as a A, Representative Western blot analysis using the whole liver lysate from STZ rats probed with anti-HNF4 or PGC-1 antibodies. The whole liver lysate (15 mg) was separated on 10% SDS-polyacrylamide gel, blotted on to a PVDF membrane, and then detected by using the anti-HNF4 and PGC-1 antibodies. The lower panels show relative protein levels as a fold of the control group values. Each value is presented as the mean AE S.E; n ¼ 4.
Ã Value indicates significant difference between the STZ control and biotin-treated groups at p < 0:05. B, The abundance of HNF4 and PGC-1 mRNA was measured by using quantitative RT-PCR and is expressed as a fold of the control group values. Each value is presented as the mean AE S.E; n ¼ 5 or n ¼ 6. a,b Values indicate significant differences among the STZ groups at p < 0:05. The association of HNF4 with the PCK1 and G6PC promoter regions was measured by chromatin immunoprecipitation as described in the Materials and Methods section and is expressed as a fold of the control group values. Each value is presented as the mean AE S.E; n ¼ 3.
therapeutic agent could improve the diabetic condition by the inhibition of gluconeogenesis.
Dakshinamurti et al. 12) have shown that the decrease in the expression of the PCK1 gene by biotin administration occurred at the transcriptional stage. We found that the reporter gene activity was significantly decreased by the biotin treatment in HepG2 cells that were transfected with a reporter plasmid having the promoter region of the rat PCK1 gene which lies upstream of the reporter gene (Sugita et al., unpublished data). Thus, lowering of the abundance of PCK1 mRNA by the biotin administration is presumed to occur at the transcriptional stage. The transcriptional mechanism for the PCK1 gene has been extensively analyzed. Transcription factors such as GR, FoxO1, HNF4, and C/EBP are involved in the regulation of this gene. Measurement of the expression levels of these factors in the liver showed both the mRNA and protein levels of HNF4 to have been significantly decreased by the biotin administration. This affected the amount of HNF4 recruited on the PCK1 promoter region. We also have a similar result regarding the promoter region of G6PC which is one of the genes regulated by HNF4 (Fig. 4) . Thus, the decrease in PCK1 mRNA could have been partially caused by the decreased expression of HNF4. Biotin is known to increase the cellular cGMP level by stimulating soluble guanylate cyclase. However, we did not observe any difference between the hepatic cGMP levels of the biotin-treated and STZ control groups 3 h after the administration (data not shown). Thus, in this experiment, cGMP and such related molecules as cGMPdependent kinase may not have been involved in the modulation of gene expression by biotin. Recently, Pirner and Stolz reported that, in yeast, the concentration of biotin in the culture medium affects the expression of the genes involved in biotin synthesis and transport. 31) The promoter region in these genes has a common nucleotide sequence, namely, the biotin response element (BRE), and a tentative transcription factor(s) is thought to bind to BRE in response to the intracellular biotin level to reduce the expression of these genes. We discovered in this experiment that the mRNA levels of at least 6 genes (PCK1, G6PC, HNF4, PGC-1, biotinidase, and PCCA) were significantly decreased by the biotin administration. There is no information on whether the biotin-regulated genes in mammals also have BRE cognate sequences in their regulatory regions; however, some biotin-dependent genes may be regulated by biotin through the BRE sequence.
Propionyl-CoA carboxylase (PCC) catalyzes the first step in the catabolism of propionyl-CoA generated from an odd number fatty acids and glycogenic amino acids (isoleucine, valine, and methionine). Therefore, the PCC pathway is partially involved in gluconeogenesis; however, it is not well known whether the PCC expression level is associated with the diabetic state. PCC consists of and subunits. The subunit of PCC is encoded by the PCCA gene and modified into a holocarboxylase by biotin. The abundance of PCCA mRNA was higher in the STZ control rats than in normal rats. The biotin treatment significantly reduced the abundance of PCCA mRNA in the STZ rats. These results suggest that biotin might inhibit gluconeogenesis through the repression of expression of the PCCA gene, in addition to the PCK1 and G6PC genes. The abundance of PGC-1 mRNA was markedly increased in the STZ diabetic rats, as compared to the normal rats (>5 times, Fig. 3B ). PGC-1 is a common transcriptional coactivator of GR, HNF4 and FoxO1, and accomplishes the key function of the increased expression of gluconeogenic enzymes in the liver. [21] [22] [23] The PGC-1 mRNA level was significantly decreased by the biotin administration. Although the PGC-1 protein level did not change within 3 h after biotin administration, a long-term biotin treatment might lead to a reduction in the PGC-1 protein level. PGC-1 is one of the therapeutic targets for improving the diabetic condition; thus, the influence of biotin on PGC-1 gene expression should be analyzed in greater detail by further experiments.
